CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and radiation therapy in people with microsatellite stable pancreatic cancer.The names of the study interventions involved in this ...
Phase 2
Boston, Massachusetts, United States and 2 other locations
This research study is studying an investigational therapy as a possible treatment for pancreatic cancer.The drugs involved in this...
Phase 2
Boston, Massachusetts, United States and 2 other locations
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Boston, Massachusetts, United States and 12 other locations
This research is being done to evaluate the safety and effectiveness of the drug NIS793 in combination with the standard of care treatment FOLFIRINOX...
Phase 1
Boston, Massachusetts, United States
This research study is studying a combination of drugs with radiation therapy as a possible treatment for Microsatellite Stable Colorectal Cancer...
Phase 2
Boston, Massachusetts, United States
This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions involved in th...
Phase 2
Boston, Massachusetts, United States and 9 other locations
gemcitabine and nab-paclitaxel, for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC) which has progressed after at least on...
Phase 2
Boston, Massachusetts, United States
with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...
Phase 3
Worcester, Massachusetts, United States of America and 89 other locations
Multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of anamorelin HCl. Approximately 100 subjects wit...
Phase 2
Burlington, Massachusetts, United States
This study is being done to test the safety and effectiveness of combining ZN-c3 and Gemcitabine in participants with pancreatic cancer...
Phase 2
Boston, Massachusetts, United States
Clinical trials
Research sites
Resources
Legal